How to Build Muscle While on Metformin

Metformin creates a real but manageable headwind against muscle growth. The most direct evidence comes from the MASTERS trial, a randomized, placebo-controlled study in older adults, which found that people taking metformin gained less lean body mass and less thigh muscle than those on placebo despite doing the same progressive resistance training program. That does not mean building muscle on metformin is impossible. It means you need a more deliberate approach to training, nutrition, and recovery than someone not taking the drug, and it helps to understand exactly where metformin interferes so you can push back at the right points.

Where Metformin Interferes With Muscle Growth

Your muscles grow primarily through a signaling pathway that senses mechanical tension and amino acids, then triggers protein synthesis. Metformin activates an energy-sensing enzyme called AMPK, which functions as a kind of cellular fuel gauge. When AMPK is switched on, it suppresses the growth-signaling pathway (mTORC1), essentially telling the cell that energy is scarce and this is not the time to build new tissue. Lab research has confirmed that metformin inhibits mTORC1 through multiple routes, including at least one that operates independently of AMPK itself.¹ In skeletal muscle cells specifically, metformin’s activation of AMPK has been shown to dampen the downstream signals that drive protein synthesis.²

Beyond suppressing growth signals, metformin can also turn up signals that break muscle down. Research in muscle cell lines found that metformin increased expression of myostatin, a protein that actively limits muscle size, through a chain involving AMPK, a transcription factor called FoxO3a, and changes to how genes are read. When researchers knocked down AMPK in those cells, myostatin expression dropped by about half and the muscle fibers grew substantially larger even in the presence of metformin.³ So metformin is working both sides: it dials down the “build” signal and dials up the “don’t build” signal. That is a genuine biochemical challenge, but it is not insurmountable.

What the MASTERS Trial Actually Showed

The most widely cited human study on this topic is the MASTERS trial, a double-blind, placebo-controlled study in healthy adults aged 65 and older. Participants took either 1,700 mg of metformin daily or a placebo for two weeks before beginning a 14-week progressive resistance training program, and they continued on their assigned pill throughout.⁴ Both groups trained with the same protocol. Both groups gained muscle. But the placebo group gained significantly more lean body mass and thigh muscle mass, and CT scans confirmed greater increases in thigh muscle area and density in the placebo group.⁵

Strength gains trended lower in the metformin group too, though the difference did not reach statistical significance. On a molecular level, the metformin group showed increased AMPK signaling and a trend toward blunted mTORC1 signaling, consistent with the mechanism described above. Transcriptome analysis from the same trial confirmed that metformin altered the gene-level response to training in ways that could limit hypertrophy, though the researchers noted that some of those changes might have benefits for aging-related pathways separate from muscle size.⁶

The key takeaway is that the metformin group still built muscle. The drug blunted the response; it did not eliminate it. And the participants were older adults, a group where the muscle-building response is already somewhat muted compared to younger people. If you are younger, the gap may be smaller, though no equivalent randomized trial in younger adults exists yet.

The Metabolic Paradox: Who Gets Hurt and Who Gets Helped

Here is where the picture gets more nuanced than “metformin is bad for muscle.” Observational studies in people with type 2 diabetes and insulin resistance consistently find that metformin users have a lower prevalence of sarcopenia, the age-related loss of muscle mass and function. A recent review framed this as a context-dependent paradox: in metabolically compromised or insulin-resistant people, metformin’s improvements to systemic metabolism and inflammation may indirectly support muscle quality and function, while in metabolically healthy, physically active older adults, that same drug blunts the anabolic response to exercise.⁷

This matters for practical decision-making. If you are taking metformin for type 2 diabetes, the metabolic benefits (better blood sugar control, lower inflammation, improved insulin sensitivity) likely do more for your overall muscle health than the blunting effect takes away. Chronic high blood sugar and insulin resistance are themselves destructive to muscle tissue. Getting those under control is step one. The muscle-building headwind from metformin is a second-order problem compared to the metabolic damage the drug is treating.

If you are taking metformin off-label, say for longevity or polycystic ovary syndrome, and you are otherwise metabolically healthy, the tradeoff is less clearly in your favor. That is a conversation worth having with your prescriber, especially if muscle gain is a high priority for you.

Use Leucine and Higher Protein Intake to Push Back

One of the most actionable findings in the research is that leucine, a branched-chain amino acid abundant in animal proteins and whey, can partially override metformin’s suppression of the growth pathway. Cell studies found that increasing leucine concentrations blunted metformin’s inhibitory effect on mTOR signaling, suggesting that the amino acid sensing machinery remains intact even under metformin, just attenuated.⁸ The practical translation: if metformin is dimming the growth signal, flooding the system with the amino acid that flips that switch may compensate, at least in part.

There is a second reason to pay extra attention to protein. A mouse study found that metformin inhibits digestive enzymes involved in breaking down protein in the gut, reducing enteropeptidase and trypsin activity and impairing protein digestion in the intestinal lumen.⁹ This is animal data and should be treated cautiously, but it does raise the possibility that metformin users absorb protein less efficiently. If even some of your dietary protein is passing through undigested, you would need to eat more of it to get the same net amino acid delivery to your muscles.

For someone on metformin trying to build muscle, aiming for the upper end of the commonly recommended protein range makes sense. Spreading your intake across multiple meals rather than concentrating it in one or two sittings may also help, since each feeding provides a separate pulse of leucine to stimulate the growth pathway. Foods naturally high in leucine, like dairy, eggs, chicken, and fish, or a whey protein supplement, are straightforward ways to keep levels elevated.

Training Harder, Not Just Longer

Since the growth signal is partially dampened by metformin, the training stimulus itself needs to be strong enough to overcome that dampening. The MASTERS trial used a standard progressive resistance training protocol, and even with metformin in the picture, participants still added muscle. The practical lesson is that resistance training works on metformin; it just works less per unit of effort.

A few principles are especially relevant:

Progressive overload: Consistently increasing the weight, reps, or sets over time ensures the growth stimulus stays above the threshold where metformin’s dampening effect would wipe it out entirely.
Sufficient volume: Training each muscle group with enough weekly sets matters more when your anabolic response per set is reduced. If you have been doing the bare minimum and expecting results, metformin is likely making that minimum insufficient.
Compound movements: Exercises that recruit large amounts of muscle tissue (squats, deadlifts, presses, rows) generate a larger systemic anabolic signal than isolation work. That bigger signal is more likely to overcome the AMPK-mediated suppression.

Resistance training should be the priority over endurance training for anyone on metformin whose primary goal is muscle gain. A study examining concurrent training (resistance plus endurance) found that participants doing exercise combined with metformin improved their cardiorespiratory fitness by only about 5%, compared to a 13% improvement in the exercise-only group.¹⁰ Separately, research has shown that metformin can blunt the mitochondrial adaptations your muscles make in response to aerobic exercise.¹¹ You do not need to eliminate cardio, but if you are limited on training time and muscle is the goal, resistance work should get the lion’s share of your effort.

Creatine and Vitamin B12: Two Supplements Worth Considering

Creatine monohydrate is one of the most studied and consistently effective supplements for muscle gain in the general population. For metformin users, it is particularly interesting because creatine works through a mechanism largely independent of the mTOR pathway that metformin suppresses. Creatine increases the energy available for high-intensity muscle contractions, lets you do more work per set, and supports cell hydration in muscle tissue. A review of studies combining creatine supplementation with exercise in people with type 2 diabetes found that the combination showed potential to improve both glucose regulation and muscle mass.¹² Since metformin already improves glucose handling, adding creatine on top could address the muscle-building side of the equation through a pathway the drug is not blocking.

Vitamin B12 is a different kind of concern. Metformin is well documented to lower B12 levels over time, and deficiency can lead to peripheral neuropathy, a condition where nerve signaling to muscles becomes impaired. One study found that patients on prolonged metformin therapy had an 11% increase in B12 deficiency, and clinical neuropathy was more prevalent in the metformin-exposed group (45%) than in the non-metformin group (about 32%).¹³ Another study in Saudi patients with type 2 diabetes found that metformin users had roughly four to five times the odds of being B12 deficient compared to non-users, though in that study, peripheral neuropathy rates did not differ significantly between groups.¹⁴ Either way, if your nerves are not firing properly, your ability to train hard and recruit muscle fibers suffers. Getting B12 levels checked periodically, and supplementing if needed, is a low-effort, high-value move for anyone on long-term metformin.

Metformin May Help Muscle Quality in Ways That Do Not Show on a Scale

Muscle is not just about size. Tissue quality matters too: how much of what looks like muscle on a scan is actually functional contractile tissue versus fat infiltration or fibrosis (scar-like collagen buildup). This is where metformin has a genuinely positive story, even for people interested in muscle performance.

In animal models of muscle disuse (think prolonged bed rest or immobilization), metformin combined with leucine reduced the collagen accumulation that normally builds up in idle muscle and improved collagen turnover during recovery.¹⁵ Separately, metformin reduced muscle fibrosis caused by joint immobilization by suppressing a fibrosis-promoting signaling pathway.¹⁶ In mice with a specific genetic deficiency causing muscle atrophy, metformin ameliorated the atrophy by improving fat metabolism and glucose utilization within the muscle itself.¹⁷

Metformin has also been shown to protect against muscle protein breakdown during disuse by attenuating markers of the ubiquitin-proteasome degradation system, the primary machinery cells use to chew up and recycle proteins.¹⁸ And in aging muscle cell models, metformin restored autophagy (the cellular cleanup process) and improved mitochondrial function, suggesting it may help maintain the health of existing muscle tissue even when it makes adding new tissue harder.¹⁹

None of this negates the hypertrophy-blunting effect. But it does mean the full picture is more complex than “metformin is bad for muscle.” The drug may be making your existing muscle healthier, more resilient, and less prone to degradation during periods when you cannot train, even as it slows the rate at which you add new tissue.

When Frailty Is Already Present

For people who are already sarcopenic or frail, the evidence tilts differently than for healthy gym-goers. A proof-of-concept trial (MET-PREVENT) tested metformin in older people with probable sarcopenia and physical frailty. After four months, walking speed, the study’s primary outcome, was essentially identical between the metformin and placebo groups, with no clinically meaningful difference detected.²⁰ So metformin alone, without structured exercise, did not rescue physical function in people who were already frail.

This lines up with the broader theme: metformin’s muscle benefits (lower inflammation, better metabolism, reduced fibrosis) are supporting actors, not the lead. Resistance training is the lead. For frail or sarcopenic individuals on metformin, the priority is getting into a supervised, progressive resistance training program. The drug is not going to replace that stimulus, but it is not going to prevent it from working either, as the MASTERS trial showed that even the metformin group gained muscle with training.

Metformin and Mitochondria During Exercise

One aspect that catches people off guard is metformin’s effect on mitochondria, the energy-producing structures inside cells. Metformin has long been thought to partially inhibit complex I, the first step in the mitochondrial electron transport chain. A study in older adults found that metformin abolished the exercise-mediated increase in skeletal muscle mitochondrial respiration.¹¹ However, more recent work has challenged whether metformin actually acts directly on complex I, suggesting the mechanism may be more indirect.²¹

Regardless of the exact mechanism, the practical consequence is real: your muscles may adapt less efficiently to endurance-type training on metformin. For someone focused on muscle building, this is not a disaster, since resistance training relies more heavily on anaerobic energy systems than on mitochondrial capacity. But if you notice that your cardio performance seems to plateau despite consistent effort, metformin could be part of the explanation. Prioritizing the type of training that matters most to you (in this case, resistance work) is the pragmatic response.

Putting It All Together in Practice

There is no secret trick that fully neutralizes metformin’s effect on muscle growth. What exists is a set of practical adjustments that, stacked together, can meaningfully close the gap:

Train with progressive overload: Resistance training is non-negotiable and should be the centerpiece of your program. Increase weight or volume over time.
Eat more protein: Aim for the higher end of recommendations, with leucine-rich sources at each meal. Whey protein is a convenient option.
Consider creatine: It works through a pathway metformin does not block and has supportive evidence in people with type 2 diabetes.
Monitor B12: Ask your doctor to check levels annually. Supplement if deficient.
Do not skip training days: Because each session’s anabolic signal is somewhat muted, consistency matters more than usual. Missing sessions compounds the problem.

The evidence is clear that metformin makes muscle growth harder but not impossible. People in randomized trials gained muscle on metformin with a standard training program. With a program that is optimized for the challenge, along with smarter nutrition, you can narrow the gap further. The drug is doing important things for your metabolic health that may ultimately serve your muscles better than the hypertrophy it costs you.